Madison, WI, United States of America

Nasia Safdar

This inventor holds 1 USPTO granted patent. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nasia Safdar. Retrieved from https://idiyas.com/inventor/nasia-safdar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nasia Safdar: Innovator in Antibiotic Research

Introduction

Nasia Safdar is a prominent inventor based in Madison, WI (US). She has made significant contributions to the field of antibiotic research, particularly in the development of new compounds to combat bacterial infections. Her work is vital in addressing the growing concern of antibiotic resistance.

Latest Patents

Nasia Safdar holds a patent for Ecteinamycin, compositions and uses thereof. This patent includes an isolated or synthesized compound of Formula I and salts thereof. The compound has a chemical formula of CHO and is designed to treat bacterial infections, including gram-positive infections. The compositions and methods outlined in her patent are crucial for advancing treatment options in the medical field.

Career Highlights

Nasia is associated with the Wisconsin Alumni Research Foundation, where she continues to innovate and contribute to research in antibiotic development. Her dedication to her work has positioned her as a key figure in her field.

Collaborations

Nasia has collaborated with notable colleagues, including Timothy Bugni and Thomas Wyche. These partnerships enhance her research efforts and contribute to the advancement of antibiotic therapies.

Conclusion

Nasia Safdar's work in antibiotic research exemplifies the importance of innovation in addressing public health challenges. Her contributions through her patent and collaborations are paving the way for new treatments against bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…